Literature DB >> 1737841

Prevention of diabetes in BB/Wor rats by intrathymic islet injection.

S B Koevary1, M Blomberg.   

Abstract

The objective of this study was to determine whether the intrathymic injection of islets can prevent the development of diabetes in BB/Wor rats. Evidence suggests that a failure to induce islet thymic tolerance may be an etiological factor in the development of the disease. It was theorized that the introduction of islets into the thymus might directly induce islet tolerance and thus prevent disease. Islets from diabetes-resistant BB/Wor rats were injected into the thymuses of 23 young diabetes-prone BB/Wor rats; 25 sham-operated animals served as controls. Results showed that 22 of the 25 control rats became diabetic while only 8 of the 23 experimental rats became diabetic (P less than 0.0002). The specific lysis of islet cells by spleen cells from nondiabetic experimental and control rats was comparable and less than the lysis induced by spleen cells from diabetic rats. These data demonstrate that the intrathymic injection of islets into diabetes-prone BB/Wor rats is an effective method for preventing the development of autoimmune type I diabetes.

Entities:  

Mesh:

Year:  1992        PMID: 1737841      PMCID: PMC442881          DOI: 10.1172/JCI115614

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Sites of the defects leading to autoimmunity in the spontaneously diabetic BB rat.

Authors:  J Scott; D C Benjamin; J C Herr; V H Engelhard
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

Review 2.  The BB rat.

Authors:  J P Mordes; J Desemone; A A Rossini
Journal:  Diabetes Metab Rev       Date:  1987-07

3.  "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.

Authors:  R Kiessling; E Klein; H Wigzell
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

4.  In vitro lysis of islet cells by lymphocytes from diabetic BB/Wor rats is not antibody mediated.

Authors:  S B Koevary
Journal:  Diabetes Res       Date:  1990-03

5.  Islet transplantation in spontaneously diabetic BB/Wor rats.

Authors:  O D Hegre; A J Enriquez; R J Ketchum; A J Weinhaus; J R Serie
Journal:  Diabetes       Date:  1989-09       Impact factor: 9.461

6.  Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens.

Authors:  V A Thomas; B A Woda; E S Handler; D L Greiner; J P Mordes; A A Rossini
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461

7.  Prevention of recurrent autoimmune diabetes in BB rats by anti-asialo-GM1 antibody.

Authors:  J D Jacobson; J F Markmann; K L Brayman; C F Barker; A Naji
Journal:  Diabetes       Date:  1988-06       Impact factor: 9.461

8.  Identity of cells that imprint H-2-restricted T-cell specificity in the thymus.

Authors:  D Lo; J Sprent
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

9.  In vitro natural killer cell activity in the spontaneously diabetic BB/Wor rat: effects of serum on lysis of insulinoma cells.

Authors:  S B Koevary
Journal:  Diabetes Res       Date:  1988-06

10.  T cell dysfunction in the diabetes-prone BB rat. A role for thymic migrants that are not T cell precursors.

Authors:  H M Georgiou; A C Lagarde; D Bellgrau
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

Review 2.  Transplantation in diabetes: a cell biological problem.

Authors:  F Purrello; D Pipeleers
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

3.  Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth.

Authors:  E H Leiter; R G Gill
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

4.  Mouse models of autoimmune disease suggest that self-tolerance is maintained by unresponsive autoreactive T cells.

Authors:  O Taguchi; T Takahashi
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

5.  Breakdown of self-tolerance by intrathymic injection of a T-cell line inducing autoimmune gastritis in mice.

Authors:  A Nishio; T Katakai; M Hosono; M Inaba; M Sakai; M Okuma; S Kasakura; T Masuda
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

6.  Thymic epithelial defects and predisposition to autoimmune disease in BB rats.

Authors:  J Doukas; J P Mordes; C Swymer; D Niedzwiecki; R Mason; J Rozing; A A Rossini; D L Greiner
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

7.  'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.

Authors:  I Ohtsuru; H Matsuo; T Fukudome; A Suenaga; M Tsujihata; S Nagataki
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

8.  Induction of tolerance to autoimmune diabetes with islet antigens.

Authors:  K C Herold; A G Montag; F Buckingham
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

9.  Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide.

Authors:  S J Khoury; M H Sayegh; W W Hancock; L Gallon; C B Carpenter; H L Weiner
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

10.  Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo.

Authors:  S J Khoury; L Gallon; W Chen; K Betres; M E Russell; W W Hancock; C B Carpenter; M H Sayegh; H L Weiner
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.